Literature DB >> 27013616

Findings from within-subjects comparisons of drug use and sexual risk behaviour in men who have sex with men in England.

G J Melendez-Torres1, Ford Hickson2, David Reid2, Peter Weatherburn2, Chris Bonell3.   

Abstract

Epidemiological evidence for the encounter-level association between sexualised drug use and unprotected anal intercourse in men who have sex with men is unclear and has not examined men who have sex with men in England. To estimate this association, we compared dyadic sexual encounters within respondents. We used encounter-level data from a longitudinal online survey of men who have sex with men living in England and multilevel models to test univariate and multivariate associations between any respondent or partner drug use, specific respondent drug use, additional situational characteristics and unprotected anal intercourse. Based on 6742 encounters from 2142 men who have sex with men, respondent drug use and respondent use of certain specific drugs were associated with increased unprotected anal intercourse odds. In univariate models, partner drug use was associated with increased unprotected anal intercourse odds, but in multivariate models, only non-specific knowledge of partner drug use was associated with the same. Encounters with non-regular-and-steady partners or that were not HIV-seroconcordant were associated with decreased unprotected anal intercourse odds. This is the first within-subjects comparison of drug use and unprotected anal intercourse conducted on a sample from England, and the largest of its kind. Findings are consistent with other studies, though associations between drug use and unprotected anal intercourse are shaped by social contexts that may change over time.

Entities:  

Keywords:  Epidemiology; high-risk behaviour; homosexual; sexual behaviour

Mesh:

Year:  2016        PMID: 27013616     DOI: 10.1177/0956462416642125

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

Review 1.  Using technology to assess and intervene with illicit drug-using persons at risk for HIV.

Authors:  Keith J Horvath; Sara Lammert; Sara LeGrand; Kathryn E Muessig; José A Bauermeister
Journal:  Curr Opin HIV AIDS       Date:  2017-09       Impact factor: 4.283

2.  Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries.

Authors:  Jamie Frankis; Paul Flowers; Lisa McDaid; Adam Bourne
Journal:  Sex Health       Date:  2018-04       Impact factor: 2.706

3.  Sexualized drug use ('chemsex') and high-risk sexual behaviours in HIV-positive men who have sex with men.

Authors:  E L Pufall; M Kall; M Shahmanesh; A Nardone; R Gilson; V Delpech; H Ward
Journal:  HIV Med       Date:  2018-01-24       Impact factor: 3.180

4.  Chemsex and Mental Health of Men Who Have Sex With Men in Germany.

Authors:  Annette Bohn; Dirk Sander; Thorsten Köhler; Nico Hees; Felix Oswald; Norbert Scherbaum; Daniel Deimel; Henrike Schecke
Journal:  Front Psychiatry       Date:  2020-11-04       Impact factor: 4.157

5.  Sexualized drug use and specialist service experience among MSM attending urban and rural sexual health clinics in England and Scotland.

Authors:  Richard Kennedy; Jennifer Murira; Kirsty Foster; Ellen Heinsbroek; Frances Keane; Nisha Pal; Lynn Chalmers; Katy Sinka
Journal:  Int J STD AIDS       Date:  2021-09-21       Impact factor: 1.359

6.  Patterns of sexualised recreational drug use and its association with risk behaviours and sexual health outcomes in men who have sex with men in London, UK: a comparison of cross-sectional studies conducted in 2013 and 2016.

Authors:  Tyrone J Curtis; Alison J Rodger; Fiona Burns; Anthony Nardone; Andrew Copas; Sonali Wayal
Journal:  Sex Transm Infect       Date:  2019-11-19       Impact factor: 3.519

7.  Evaluating the impact of COVID-19: A cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A.

Authors:  Tyrel J Starks; S Scott Jones; Daniel Sauermilch; Matthew Benedict; Trinae Adebayo; Demetria Cain; Kit N Simpson
Journal:  Drug Alcohol Depend       Date:  2020-08-28       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.